[Federal Register Volume 67, Number 234 (Thursday, December 5, 2002)]
[Notices]
[Pages 72430-72431]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-30795]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Antitrust Division


Notice Pursuant to the National Cooperative Research and 
Production Act of 1993--Surface Logix, Inc.

    Notice is hereby given that, on October 30, 2002, pursuant to 
section 6(a) of the National Cooperative Research and Production Act of 
1993, 15 U.S.C. 4301 et seq. (``the Act''), Surface Logix, Inc. has 
filed written notifications simultaneously with the Attorney General 
and the Federal Trade Commission disclosing (1) the identities of the 
parties and (2) the nature and objectives of the venture. The 
notifications were filed for the purpose of invoking the Act's 
provisions limiting the recovery of antitrust plaintiffs to actual 
damages under specified circumstances. Pursuant to section 6(b) of the 
Act, the identities of the parties are Surface Logix, Inc., Brighton, 
MA; and Ancora Pharmaceuticals, Inc., Cambridge, MA. The nature and 
objectives of the venture are to execute a 3-year project to facilitate 
carbohydrate-based drug discovery and research by developing and 
integrating a variety of new technologies tailored to carbohydrate 
production and detection of their interactions. These technologies 
include automated synthesis methods to rapidly produce complex 
carbohydrates (Ancora), a unique surface chemistry platform with which 
to present these molecules, and a surface-based

[[Page 72431]]

detection system (Surface Logix). These tools will be used to design 
quantitative, reproductible assays containing many of the carbohydrate 
variants found in specific biological interactions. These assays will 
be configured to measure key interactions between carbohydrates and 
other biomolecules, thus enabling carbohydrate-based drug discovery.

Constance K. Robinson,
Director of Operations, Antitrust Division.
[FR Doc. 02-30795 Filed 12-4-02; 8:45 am]
BILLING CODE 4410-11-M